Cardionomic, Inc. was a privately held company focused on developing novel therapies for acute decompensated heart failure. The company was backed by notable investors including the Cleveland Clinic Foundation and Abbott Laboratories. Its lead technology is the Cardiac Pulmonary Nerve Stimulation (CPNS) System.